Comprehensive real-world comparisons between baricitinib and dupilumab treatments for moderate to severe atopic dermatitis

J Allergy Clin Immunol Pract. 2024 Apr 10:S2213-2198(24)00392-1. doi: 10.1016/j.jaip.2024.04.008. Online ahead of print.
No abstract available